SUPN
Supernus Pharmaceuticals Inc
Price:  
28.94 
USD
Volume:  
366,263.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SUPN Relative Valuation

-103.4%
Upside

As of 2024-07-17, the Relative Valuation of Supernus Pharmaceuticals Inc (SUPN) is (0.98) USD. This relative valuation is based on P/E multiples. With the latest stock price at 28.94 USD, the upside of Supernus Pharmaceuticals Inc based on Relative Valuation is -103.4%.

The range of the Relative Valuation is (3.05) - 1.83 USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 10.8x - 20.2x 13.3x
Forward P/E multiples 19.2x - 20.6x 20.2x
Fair Price (3.05) - 1.83 (0.98)
Upside -110.5% - -93.7% -103.4%
28.94 USD
Stock Price
(0.98) USD
Fair Price

SUPN Relative Valuation - Historical P/E Data

Date P/E
2024-07-17 -102.88
2024-07-16 -102.63
2024-07-15 -101.88
2024-07-12 -101.49
2024-07-11 -101.03
2024-07-10 -97.45
2024-07-09 -94.65
2024-07-08 -93.05
2024-07-05 -92.31
2024-07-03 -92.24
2024-07-02 -91.39
2024-07-01 -94.15
2024-06-28 -94.86
2024-06-27 -95.29
2024-06-26 -94.76
2024-06-25 -94.01
2024-06-24 -95.43
2024-06-21 -95.89
2024-06-20 -95.04
2024-06-18 -94.54
2024-06-17 -92.17
2024-06-14 -92.17
2024-06-13 -94.19
2024-06-12 -96.03
2024-06-11 -92.91
2024-06-10 -92.88
2024-06-07 -93.12
2024-06-06 -96.28
2024-06-05 -97.66
2024-06-04 -99.01
2024-06-03 -97.91
2024-05-31 -96.17
2024-05-30 -94.22
2024-05-29 -94.22
2024-05-28 -96.00
2024-05-24 -97.56
2024-05-23 -98.48
2024-05-22 -98.83
2024-05-21 -99.47
2024-05-20 -102.02
2024-05-17 -103.20
2024-05-16 -103.41
2024-05-15 -101.92
2024-05-14 -102.73
2024-05-13 -105.25
2024-05-10 -102.70
2024-05-09 -106.39
2024-05-08 -111.00
2024-05-07 -110.46
2024-05-06 -107.88